Top Menu

Coronavirus News

Read IUPHAR’s Response to COVID-19 here.

Read the latest WHO Reports on COVID-19 here:
WHO Situation Reports
WHO Situation Dashboard

Important Pharmacology Links for COVID-19:
Statement from the IUPHAR Clinical Division in Response to the COVID-19 Pandemic
Emergency Use Pathways (EUPs): Applying Regulatory Flexibility in the Age of COVID-19
EACPT Statement on Drugs and Worsening of COVID-19
CNPHARS-IUPHAR 2020-04-07 Meeting Final Summary Report

CNPHARS Summary of Activities on Anti-COVID-19
IUPHAR/BPS Guide To Pharmacology Ligands and Resources Coronavirus Information Page
Core Outcome Set for Clinical Trials on Coronavirus Disease 2019
Anit-Viral and Anti-Inflammatory Activity Against SARS-CoV-2
Watch IUIS Webinars on Immunopharmacology in Relation to Covid-19 here
Italian Society of Pharmacology COVID-19 Updates
SIF Statement on the Use of ACE- Inhibitors or Angiotensin Receptor Blockers in COVID-19 Infection
SIF Statement on Non-steroidal Anti-inflammatory Drugs (NSAIDs) and the Increased Risk of Complications During Infections
The French Society of Pharmacology and Therapeutics COVID-19 Updates
The British Pharmacological Society COVID-19 Response
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19) A Review
COVID-19 Clinical Trials at a Glance
World Allergic Organization (WAO) COVID-19 Q&A
COVID-19 Chloroquine and Hydroxycloroquine Recommendations by SFPT
Guidelines for the Treatment of Critically Ill COVID-19 Patients
Drug Use Recommendations for Healthcare Professionals and the General Public from Geneva University Hospitals
Malaga Biomedical Research Institute COVID-19 Scientific News Directory

European Medicines Agency Response on Non-Steroidal Anti-Inflammatories for COVID-19
Wiley Online Library

Wellcome